Loading clinical trials...
Loading clinical trials...
An Open-Label Multicenter, Randomized, Phase 3 Study of S-1 in Combination With Cisplatin Against 5-Fu in Combination W/ Cisplatin in Patients W/ Advanced Gastric Cancer Previously Untreated W/ Chemotherapy for Advanced Disease
Conditions
Interventions
S-1/Cisplatin
5-FU/cisplatin
Locations
33
United States
Clearview Cancer Center
Huntsville, Alabama, United States
Saint Joseph Medical Center
Burbank, California, United States
Dr. Ronald Yanagihara
Gilroy, California, United States
Norris Cancer Center
Los Angeles, California, United States
Comprehensive Cancer Center
Palm Springs, California, United States
Saint Francis Memorial Hospital
San Francisco, California, United States
Start Date
May 1, 2005
Primary Completion Date
March 1, 2008
Completion Date
April 1, 2008
Last Updated
September 19, 2024
NCT04704661
NCT04550494
NCT05489211
NCT04674267
NCT05702229
NCT07217704
Lead Sponsor
Taiho Oncology, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions